Multiple sclerosis: Possibility of a gut environment-induced disease

Neurochem Int. 2019 Nov:130:104475. doi: 10.1016/j.neuint.2019.104475. Epub 2019 May 30.

Abstract

Multiple sclerosis is a putative autoimmune disease of the central nervous system, a representative disease of 'neuroimmunology.' We now understand that gut microbiota constitutes an integral part of our body and play critical roles in various neurological diseases with which no intestinal pathology was previously associated. In fact, several reports from Japan, North America, and Europe confirmed dysbiosis of the gut microbiome in MS patients. Given the increase in the prevalence of MS worldwide, especially in Japan, some previously unknown causal environmental factors needed to be identified to inhibit the development of MS in future generations. In this review, we will introduce recent key topics related to MS pathogenesis and immune cells linking gut and brain, and then summarize studies on gut microbiome in MS and its mouse model. Lastly, we will discuss the potential role of diet in the development of MS and propose a hypothesis that could explain the dramatic increase in the number of patients suffering with MS in Japan in the past few decades.

Keywords: Butyrate; Dysbiosis; EAE; Microbiome; Multiple sclerosis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Diet, Western / adverse effects
  • Dysbiosis / diagnosis
  • Dysbiosis / epidemiology
  • Dysbiosis / immunology*
  • Encephalomyelitis, Autoimmune, Experimental / immunology
  • Encephalomyelitis, Autoimmune, Experimental / pathology
  • Environmental Exposure / adverse effects*
  • Gastrointestinal Microbiome / physiology*
  • Humans
  • Multiple Sclerosis / diagnosis
  • Multiple Sclerosis / epidemiology
  • Multiple Sclerosis / immunology*